6606
vs
H
Hang Seng (Hong Kong)
6606
Over the past 12 months, New Horizon Health Ltd has underperformed Hang Seng (Hong Kong), delivering a return of 0% compared to the Hang Seng (Hong Kong)'s +16% growth.
Stocks Performance
6606 vs Hang Seng (Hong Kong)
Performance Gap
6606 vs Hang Seng (Hong Kong)
Performance By Year
6606 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
New Horizon Health Ltd
Glance View
New Horizon Health Ltd. operates as an investment holding company. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-02-18. The firm distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.